Synergy Pharma (SGYP) Reaches Agreement with FDA for Pecanatide Phase 3
Tweet Send to a Friend
Synergy Pharma (Nasdaq: SGYP) announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE